PHASE I CLINICAL TRIAL TARGETING CD20+NON-HODGKIN'S LYMPHOMA (NHL) AFTER AUTOLOGOUS STEM CELL TRANSPLANT WITH ANTI-CD3 x ANTI-CD20 BISPECIFIC ANTIBODY ARMED T CELLS

被引:1
|
作者
Lum, L. G. [1 ]
Thakur, A. [1 ]
Ratanatharathorn, V [1 ]
Al-Kadhimi, Z. [1 ]
Paul, E. [1 ]
Skuba, C. [2 ]
Steel, P. [1 ]
Ayash, L. [1 ]
Abidi, M. [1 ]
Wedge, J. [1 ]
Uberti, J. P. [1 ]
机构
[1] Karmanos Canc Inst, Detroit, MI USA
[2] Michigan State Univ, Coll Vet Med, E Lansing, MI 48824 USA
关键词
D O I
10.1016/j.bbmt.2010.12.027
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
23
引用
收藏
页码:S158 / S159
页数:2
相关论文
共 50 条
  • [21] Treatment of B cell low grade non-Hodgkin's lymphoma (NHL) with anti-CD20 monoclonal antibody Rituximab®
    Federico, M
    Clo, V
    Vinci, G
    Sacchi, S
    ANNALS OF ONCOLOGY, 1998, 9 : 32 - 32
  • [22] Preliminary Safety and Anti-Tumor Activity of XmAb13676, an Anti-CD20 x Anti-CD3 Bispecific Antibody, in Patients with Relapsed/Refractory Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia
    Patel, Krish
    Michot, Jean-Marie
    Chanan-Khan, Asher A.
    Salles, Gilles A.
    Cartron, Guillaume
    Peyrade, Frederic
    Bouabdallah, Reda
    Reid, Erin G.
    Thomas, Sheeba K.
    Wierda, William G.
    Liebowitz, David
    Pagel, John M.
    Ribrag, Vincent
    Saville, M. Wayne
    Johnson, Chelsea M.
    Ly, Thomas
    Phillips, Tycel J.
    BLOOD, 2019, 134
  • [23] Peripheral T-cell lymphoma after anti-CD20 antibody therapy
    Tetreault, S
    Abler, SL
    Robbins, B
    Saven, A
    JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (04) : 1635 - 1636
  • [24] Targeting Cytomegalovirus-Infected Cells Using T Cells Armed with Anti-CD3 x Anti-CMV Bispecific Antibody
    Lum, Lawrence G.
    Ramesh, Mayur
    Thakur, Archana
    Mitra, Subhashis
    Deol, Abhinav
    Uberti, Joseph P.
    Pellett, Philip E.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2012, 18 (07) : 1012 - 1022
  • [25] Combining anti-CD3 activated T cells armed with anti-CD3 x anti-Her2 bispecific antibody may provide an additional anti-tumor effect after stem cell transplant for breast cancer.
    Sen, M
    Wankowski, DM
    Lum, LG
    EXPERIMENTAL HEMATOLOGY, 1998, 26 (08) : 743 - 743
  • [26] Combination anti-CD20 immunotherapy and pretargeted anti-CD20 radioimmunotherapy (PT-RAIT) of non-Hodgkin lymphoma (NHL) shows improved efficacy
    Goldenberg, David M.
    Karacay, Habibe
    Chang, Chien-Hsing
    Rossi, Edmund A.
    McBride, William J.
    Sharkey, Robert M.
    JOURNAL OF NUCLEAR MEDICINE, 2009, 50
  • [27] Impact of pre-transplant rituximab on clinical outcome after autologous haematopoietic stem cell transplantation in patients with CD20+non-Hodgkin's lymphoma
    Moscato, T.
    Fedele, R.
    Messina, G.
    Console, G.
    Martino, M.
    Massara, E.
    Princi, D.
    Irrera, G.
    Iacopino, P.
    BONE MARROW TRANSPLANTATION, 2011, 46 : S253 - S253
  • [28] Anti-CD20/CD3 T cell-dependent bispecific antibody for the treatment of B cell malignancies
    Sun, Liping L.
    Ellerman, Diego
    Mathieu, Mary
    Hristopoulos, Maria
    Chen, Xiaocheng
    Li, Yijin
    Yan, Xiaojie
    Clark, Robyn
    Reyes, Arthur
    Stefanich, Eric
    Mai, Elaine
    Young, Judy
    Johnson, Clarissa
    Huseni, Mahrukh
    Wang, Xinhua
    Chen, Yvonne
    Wang, Peiyin
    Wang, Hong
    Dybdal, Noel
    Chu, Yu-Waye
    Chiorazzi, Nicholas
    Scheer, Justin M.
    Junttila, Teemu
    Totpal, Klara
    Dennis, Mark S.
    Ebens, Allen J.
    SCIENCE TRANSLATIONAL MEDICINE, 2015, 7 (287)
  • [29] Bi20 (FBTA05), a novel trifunctional bispecific antibody (anti-CD20 x anti-CD3), mediates efficient killing of B-cell lymphoma cells even with very low CD20 expression levels
    Stanglmaier, Michael
    Faltin, Margot
    Ruf, Peter
    Bodenhausen, Annette
    Schroeder, Petra
    Lindhofer, Horst
    INTERNATIONAL JOURNAL OF CANCER, 2008, 123 (05) : 1181 - 1189
  • [30] Targeting advanced pancreatic cancer with activated t cells armed with anti-CD3 x anti-EGFR bispecific antibody.
    Lum, Lawrence G.
    Choi, Minsig
    Tri Minh Le
    Thakur, Archana
    Deol, Abhinav
    Ballen, Karen K.
    Volodin, Leonid
    Kindwall-Keller, Tamila L.
    Liu, Qin
    Dyson, Gregory
    Shields, Anthony Frank
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)